Could the efficacy of docetaxel in prostate cancer patients be potentiated by concomitant high-dose calcitriol administration?
Berruti
Alfredo
A
Tucci
Marcello
M
Mosca
Alessandra
A
Ardine
Mara
M
Poggio
Massimiliano
M
Saini
Andrea
A
Russo
Lucianna
L
Vana
Federica
F
Dogliotti
Luigi
L
D000970:Antineoplastic Agents / Q000008:administration & dosage; D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D001859:Bone Neoplasms / Q000150:complications / Q000556:secondary; D002117:Calcitriol / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D000077143:Docetaxel; D004357:Drug Synergism; D006801:Humans; D006996:Hypocalcemia / Q000209:etiology / Q000517:prevention & control; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D043823:Taxoids / Q000008:administration & dosage*
D000970:Antineoplastic Agents; D050071:Bone Density Conservation Agents; D043823:Taxoids; D000077143:Docetaxel; D002117:Calcitriol